Litigation in Israel and U.S. Mires RNA Drug Developer Arcturus
Xconomy
MAY 3, 2018
In the five years since it was founded, San Diego-based Arcturus Therapeutics (NASDAQ: ARCT ) says it has built a versatile platform for developing a variety of RNA-based medicines. Dueling lawsuits between the ousted CEO and the board could consume. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Let's personalize your content